• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

经静脉导线拔除术联合激光可减少术中股静脉入路的需求。

Transvenous lead extraction with laser reduces need for femoral approach during the procedure.

机构信息

The Leviev Heart Center, Sheba Medical Center, Ramat Gan, Israel.

Sackler School of Medicine, Tel Aviv University, Tel Aviv, Israel.

出版信息

PLoS One. 2019 Apr 29;14(4):e0215589. doi: 10.1371/journal.pone.0215589. eCollection 2019.

DOI:10.1371/journal.pone.0215589
PMID:31034499
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC6488060/
Abstract

INTRODUCTION

Cardiac implantable electronic device (CIED) trans venous lead extraction (TLE) is technically challenging. Whether the use of a laser sheath reduces complications and improves outcomes is still in debate. We therefore aimed at comparing our experience with and without laser in a large referral center.

METHODS

Information of all patients undergoing TLE was collected prospectively. We retrospectively compared procedural outcomes prior to the introduction of the laser sheath lead extraction technique to use of laser sheath.

RESULTS

During the years 2007-2017, there were 850 attempted lead removals in 407 pts. Of them, 339 (83%) were extracted due to infection, device upgrade/lead malfunction in 42 (10%) cases, and other (7%). Complete removal (radiological success) of all leads was achieved in (88%). Partial removal was achieved in another 6% of the patients. Comparison of cases prior to and after laser technique introduction, showed that with laser, a significantly smaller proportion of cases required conversion to femoral approach [31/275 (6%) laser vs. 40/132 (15%) non-laser; p<0.001]. However, success rates of removal [259/275 (94%) vs. 124/132 (94%) respectively; p = 0.83] and total complication rates [35 (13%) vs. 19 (14%) respectively; p = 0.86] did not differ prior to and after laser use. In multivariate analysis, laser-assisted extraction was an independent predictor for no need for femoral extraction (OR = 0.39; 95% CI 0.23-0.69; p = 0.01).

CONCLUSION

Introduction of laser lead removal resulted in decreased need to convert to femoral approach, albeit without improving success rates or preventing major complications.

摘要

简介

心脏植入式电子设备(CIED)经静脉导线拔除(TLE)具有一定技术难度。激光鞘的应用是否能减少并发症并改善结局仍存在争议。因此,我们旨在比较在一家大型转诊中心应用和不应用激光鞘的经验。

方法

前瞻性收集所有接受 TLE 患者的信息。我们回顾性比较了在引入激光鞘导线拔除技术之前与应用激光鞘之后的手术结果。

结果

在 2007 年至 2017 年期间,有 407 名患者中的 850 次尝试进行了导线拔除。其中,339 例(83%)因感染、器械升级/导线故障而拔除,42 例(10%)因其他原因而拔除。所有导线均成功(影像学成功)拔除 88%。另外 6%的患者部分拔除。比较激光技术引入前后的病例,发现应用激光时,需要转换为股静脉入路的病例明显减少[31/275(6%)激光 vs. 40/132(15%)非激光;p<0.001]。然而,拔除成功率[259/275(94%)与 124/132(94%);p = 0.83]和总并发症发生率[35(13%)与 19(14%);p = 0.86]在激光使用前后并无差异。多变量分析显示,激光辅助拔除是无需股静脉入路的独立预测因素(OR = 0.39;95%CI 0.23-0.69;p = 0.01)。

结论

尽管激光导线拔除并未提高成功率或预防严重并发症,但可降低需要转换为股静脉入路的需求。

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/e8b9/6488060/f8c0085049b2/pone.0215589.g001.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/e8b9/6488060/f8c0085049b2/pone.0215589.g001.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/e8b9/6488060/f8c0085049b2/pone.0215589.g001.jpg

相似文献

1
Transvenous lead extraction with laser reduces need for femoral approach during the procedure.经静脉导线拔除术联合激光可减少术中股静脉入路的需求。
PLoS One. 2019 Apr 29;14(4):e0215589. doi: 10.1371/journal.pone.0215589. eCollection 2019.
2
Large, single-center, single-operator experience with transvenous lead extraction: outcomes and changing indications.经静脉导线拔除术的大型单中心单术者经验:结果与适应证的变化
Heart Rhythm. 2008 Apr;5(4):520-5. doi: 10.1016/j.hrthm.2008.01.009. Epub 2008 Jan 17.
3
Outcomes and costs associated with two different lead-extraction approaches: a single-centre study.两种不同的导线拔除方法相关的结果和成本:一项单中心研究。
Europace. 2017 Oct 1;19(10):1710-1716. doi: 10.1093/europace/euw254.
4
The analysis of indications and early results of transvenous lead extraction in patients with a pacemaker, ICD and CRT - single-center experience.起搏器、植入式心律转复除颤器(ICD)和心脏再同步治疗(CRT)患者经静脉导线拔除的适应证分析及早期结果——单中心经验
Acta Cardiol. 2015 Dec;70(6):685-92. doi: 10.2143/AC.70.6.3120181.
5
Transvenous Lead Extraction in Adults With Congenital Heart Disease: Insights From a 20-Year Single-Center Experience.成人先天性心脏病患者的经静脉心内导线拔除术:来自 20 年单中心经验的见解。
Circ Arrhythm Electrophysiol. 2018 Feb;11(2):e005409. doi: 10.1161/CIRCEP.117.005409.
6
Transvenous lead extraction at the time of cardiac implantable electronic device upgrade: Complexity, safety, and outcomes.经静脉心脏植入式电子设备升级时的导线拔除术:复杂性、安全性和结果。
Heart Rhythm. 2017 Dec;14(12):1807-1811. doi: 10.1016/j.hrthm.2017.08.019. Epub 2017 Aug 23.
7
Extraction of old pacemaker or cardioverter-defibrillator leads by laser sheath versus femoral approach.经激光鞘管与股动脉入路提取旧起搏器或除颤器导线的比较。
Circ Arrhythm Electrophysiol. 2010 Aug;3(4):319-23. doi: 10.1161/CIRCEP.109.933051. Epub 2010 Jun 19.
8
Laser-assisted extraction of pacemaker and defibrillator leads: the role of the cardiac surgeon.激光辅助拔除起搏器和除颤器导线:心脏外科医生的作用。
Ann Thorac Surg. 2009 May;87(5):1446-50; discussion 1450-1. doi: 10.1016/j.athoracsur.2009.02.015.
9
Transvenous lead extraction in patients with prior extraction procedures: Procedural profiles and outcomes.经静脉导线拔除术在有既往拔除术史的患者中的应用:操作特点和结果。
Heart Rhythm. 2020 Nov;17(11):1904-1908. doi: 10.1016/j.hrthm.2020.05.042. Epub 2020 Jun 5.
10
Initial experience with the TightRail™ Rotating Mechanical Dilator Sheath for transvenous lead extraction.用于经静脉导线拔除的TightRail™旋转机械扩张器鞘管的初步经验。
Europace. 2016 Jul;18(7):1043-8. doi: 10.1093/europace/euv245. Epub 2015 Oct 14.

引用本文的文献

1
Leadless Pacemaker Implantation During Extraction in Patients with Active Infection: A Comprehensive Analysis of Safety, Patient Benefits and Costs.活动性感染患者拔除时无导线起搏器植入:安全性、患者获益及成本的综合分析
J Clin Med. 2025 Aug 2;14(15):5450. doi: 10.3390/jcm14155450.
2
Comparison of non-laser and laser transvenous lead extraction: a systematic review and meta-analysis.非激光与激光经静脉心脏起搏器/除颤器导线拔除的比较:系统评价和荟萃分析。
Europace. 2023 Nov 2;25(11). doi: 10.1093/europace/euad316.
3
Complicated Pocket Infection in Patients Undergoing Lead Extraction: Characteristics and Outcomes.

本文引用的文献

1
2017 HRS expert consensus statement on cardiovascular implantable electronic device lead management and extraction.2017年心律学会心血管植入式电子装置导线管理与拔除专家共识声明
Heart Rhythm. 2017 Dec;14(12):e503-e551. doi: 10.1016/j.hrthm.2017.09.001. Epub 2017 Sep 15.
2
Cardiac implantable electronic device lead extraction using the lead-locking device system: keeping it simple, safe, and inexpensive with mechanical tools and local anesthesia.使用导线锁定装置系统进行心脏植入式电子设备导线拔除:借助机械工具和局部麻醉,使其操作简便、安全且成本低廉。
Anatol J Cardiol. 2017 Oct;18(4):289-295. doi: 10.14744/AnatolJCardiol.2017.7821. Epub 2017 Aug 11.
3
导线拔除患者的复杂囊袋感染:特征与结局
J Clin Med. 2023 Jun 29;12(13):4397. doi: 10.3390/jcm12134397.
4
Occluded vein as a predictor for complications in non-infectious transvenous lead extraction.闭塞静脉作为非感染性经静脉导线拔除并发症的预测指标
Front Cardiovasc Med. 2022 Oct 4;9:1016657. doi: 10.3389/fcvm.2022.1016657. eCollection 2022.
Non-laser percutaneous extraction of pacemaker and defibrillation leads: a decade of progress.
非激光经皮起搏器和除颤器导线拔除术:十年来的进展。
Europace. 2017 Sep 1;19(9):1521-1526. doi: 10.1093/europace/euw162.
4
Outcomes and costs associated with two different lead-extraction approaches: a single-centre study.两种不同的导线拔除方法相关的结果和成本:一项单中心研究。
Europace. 2017 Oct 1;19(10):1710-1716. doi: 10.1093/europace/euw254.
5
Laser lead extraction allows for safe and effective removal of single- and dual-coil implantable cardioverter defibrillator leads: A single-centre experience over 12 years.激光导线拔除术可安全有效地移除单线圈和双线圈植入式心脏复律除颤器导线:一项为期12年的单中心经验。
Interact Cardiovasc Thorac Surg. 2017 Jan;24(1):77-81. doi: 10.1093/icvts/ivw298. Epub 2016 Sep 13.
6
How adequate are the current methods of lead extraction? A review of the efficiency and safety of transvenous lead extraction methods.目前的铅提取方法有多充分?经静脉铅提取方法的效率和安全性综述。
Europace. 2015 May;17(5):689-700. doi: 10.1093/europace/euu378. Epub 2015 Feb 16.
7
Trends in the incidence and prevalence of cardiac pacemaker insertions in an ageing population.老年人群中心脏起搏器植入的发病率和患病率趋势。
Open Heart. 2014 Dec 10;1(1):e000177. doi: 10.1136/openhrt-2014-000177. eCollection 2014.
8
Twenty-year experience of transvenous lead extraction at a single centre.单中心经静脉导线拔除术的20年经验。
Europace. 2014 Sep;16(9):1350-5. doi: 10.1093/europace/eut424. Epub 2014 Feb 19.
9
From lead management to implanted patient management: systematic review and meta-analysis of the last 15 years of experience in lead extraction.从铅管理到植入患者管理:对过去 15 年铅提取经验的系统回顾和荟萃分析。
Expert Rev Med Devices. 2013 Jul;10(4):551-73. doi: 10.1586/17434440.2013.811837.
10
The 11th world survey of cardiac pacing and implantable cardioverter-defibrillators: calendar year 2009--a World Society of Arrhythmia's project.第11次心脏起搏与植入式心律转复除颤器全球调查:2009日历年——一项世界心律失常学会的项目
Pacing Clin Electrophysiol. 2011 Aug;34(8):1013-27. doi: 10.1111/j.1540-8159.2011.03150.x. Epub 2011 Jun 27.